Genome Editing in Mammalian Cell Lines using CRISPR-Cas.

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system, originally from bacterial adaptive immunity, is a powerful tool for genome engineering.
• CRISPR-Cas endonucleases like Cas9 and Cas12a create DNA double-stranded breaks, repaired by Non-Homologous End Joining (NHEJ) or Homology-Directed Repair (HDR).
• While effective in mammalian cells, CRISPR genome editing requires careful consideration of multiple design parameters.

Purpose of the Study:

• To provide a complete workflow for successful genome editing experiments in mammalian cell lines.
• To address user perplexity regarding optimal experimental design for CRISPR applications.
• To facilitate gene knockout studies, disease modeling, and reporter cell line generation.

Main Methods:

• Development of a detailed experimental workflow from initial design to final clone identification.
• Highlighting critical design considerations including CRISPR system selection, spacer length optimization, and single-stranded oligodeoxynucleotide (ssODN) donor template design.
• Focus on practical execution for achieving desired DNA modifications in mammalian cells.

Main Results:

• A structured approach to CRISPR genome editing is described, covering all essential steps.
• Key parameters influencing the success of genome editing experiments are identified and explained.
• The workflow aims to simplify and improve the efficiency of generating genetically modified mammalian cell lines.

Conclusions:

• The presented workflow simplifies CRISPR genome editing in mammalian cells, enabling researchers to achieve desired DNA modifications more reliably.
• This standardized approach is valuable for various applications, including functional genomics and disease research.
• Successful implementation of this workflow can accelerate the generation of engineered cell lines for diverse biological studies.